The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. - Wikidata - awgldk - TriplyDB

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.

http://www.wikidata.org/entity/Q34943776

about

Cytotoxic and targeted therapy for hereditary cancers Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?Tertiary Lymphoid Organs in Cancer Tissues The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer Cancer immunotherapy: the beginning of the end of cancer?Cytokine-Induced Modulation of Colorectal Cancer PD-1/PD-L1 blockades in non-small-cell lung cancer therapy The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer New therapeutic strategies for BRAF mutant colorectal cancers Targeted therapy for advanced gastric cancer: A review of current status and future prospects Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy Immune cell interplay in colorectal cancer prognosis Current and future molecular profiling of cancer by next-generation sequencing Antagonists of PD-1 and PD-L1 in Cancer Treatment Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockade Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy.Opportunities for immunotherapy in microsatellite instable colorectal cancer Recent advances in understanding antitumor immunity Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective Immunological battlefield in gastric cancer and role of immunotherapies Current debate in the oncologic management of rectal cancer.PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation Current Status and Perspective of Immunotherapy in Gastrointestinal Cancers The role of immune checkpoint inhibition in the treatment of ovarian cancer Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer Immune checkpoint blockade: a common denominator approach to cancer therapy Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer From mice to humans: developments in cancer immunoediting PD-1 Blockade in Tumors with Mismatch-Repair Deficiency A panoply of errors: polymerase proofreading domain mutations in cancer Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Lynch syndrome-related small intestinal adenocarcinomas.Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress Dissecting microsatellite instability in colorectal cancer: one size does not fit all Prognostic value of programmed death-ligand 1 expression in patients with stage III colorectal cancer

P2860

Q26739366-F9703C71-9130-4190-999E-8C4B5C8DD55E Q26742047-A11A0C5B-C50F-4195-AE5D-FB0B4631E9DB Q26742168-300F29EE-55EF-4D1F-9AB3-102F2C3C3069 Q26745580-76035376-F257-4600-B22B-E689DBD41125 Q26747329-D8414543-C079-4D98-8DAC-D7BDAE96F7B5 Q26752277-7D33AF4F-63B9-4F80-909E-147EE975B3EA Q26752374-3800288A-8EB3-46D1-82AD-FE485EC10A4C Q26765024-4CF8854F-0083-425E-ACDD-F9092A72B8C7 Q26766285-4A413A8C-AAF9-4A98-8EA2-AF6700CF3C91 Q26772277-E3AF3003-B6D4-4EF6-AE8C-3CE54A54782E Q26774138-EDCA9971-E296-443A-BC15-D0AA7A249011 Q26774690-69BC6322-A437-49CC-A140-9E5DE2FC1126 Q26775578-11A72973-8C98-4863-A89B-8C0A341ECA72 Q26778793-5B605599-599C-4054-9AC4-BE51B70B8A85 Q26779184-4E90B7E5-60FA-4B6A-A5CC-34D877445AFF Q26781453-82A03610-1C7E-4980-BDBF-44C400B16855 Q26796272-33690124-51CD-4D73-B394-CD120E2545EF Q26796311-5CA212D8-BD61-44F4-B007-565471F44210 Q26801856-53ECACC8-98C3-44F9-993B-134E32216431 Q27686800-15BEEAAB-AA02-4A41-9BC9-ECD4C8C6851C Q28066110-99B70A9C-C265-499D-9DFA-4E490E7BC22B Q28067217-95783091-E380-4B39-B8A2-4F76582AA4D2 Q28070038-33B8C208-E65B-471A-8F3A-BE7AF998626F Q28071836-6CBF74C5-E57C-4D6E-B020-20BDC044DB6D Q28072948-72BD0A91-03BA-4E09-BD9C-4387C9089197 Q28075712-0DC9793C-0EA8-4F24-A006-27E0005489E3 Q28075719-250FB90C-E16E-4191-AC2E-1E94B84EB66C Q28076970-D4F033FD-8951-4984-9E29-6136841B51B9 Q28077924-AA7413B7-E514-4830-9782-B129B31B1C27 Q28080176-58275C84-EDF6-46BB-81AF-C46E43C93DCC Q28083981-F9F720F7-7D8B-4761-AE3C-D988807E6FDA Q28084346-14D0E078-015B-44D4-B6BA-EF5E990930BC Q28088304-48703A1E-06DC-4AB6-8560-17627BAB2CDE Q28262647-8C67ED91-1352-494E-A411-A5D25C4364C8 Q28272700-54006466-7EBE-4786-9383-6F35CB87AB08 Q30244608-416FF43D-6430-4BEA-883B-DC1EC65CCEA3 Q33591577-8237EB5B-431C-4684-99DA-8E2B141ECE8A Q33593871-D593EB09-9DBA-4406-955E-C90291CA3E69 Q33722794-A81A2541-EC4E-4F14-B434-09B6F575E394 Q33738756-3CAA3757-3847-49F4-81DF-EA2E8B52E9C0

P2860

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.

http://www.wikidata.org/entity/Q34943776

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@ast

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@en

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@nl

type

label

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@ast

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@en

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@nl

prefLabel

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@ast

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@en

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@nl

P1433

Q34943776-773550BF-2685-4FB5-983F-5708FB60D596

P1476

Q34943776-5AFA2A5D-CDA4-4538-A220-261183C71ADB

P2093

Q34943776-0B60ED63-BD9F-4844-A87B-A3A56A64BA12

Q34943776-11AE62EB-53CF-4335-A0FA-5C21204BA4C5

Q34943776-1B0EA1AD-F12A-4B56-90B6-E4DF883FE03E

Q34943776-4D1F5C82-9822-4FD2-A969-7146CA98BB38

Q34943776-5EFA48F6-7C6A-420E-A13E-8A201E482CE0

Q34943776-7691FD50-8CAF-4B60-9D15-CABF9FD9E60D

Q34943776-84BAA1EC-3FC1-4D0E-AAB3-4259AB646213

Q34943776-8C6C7E16-29BB-4704-A599-E248C75977D6

Q34943776-90705055-8EFF-4E6B-877C-615A916EE6F0

Q34943776-90E8B769-495D-4BAF-9380-7F261186C986

P2860

Q34943776-01590C13-993D-48BA-A9B8-F891BE4E86CA

Q34943776-0B5F2DB7-86CE-4E6F-B52E-32739BC3E76E

Q34943776-0E588EBD-4CD0-4C84-AA85-46402090597C

Q34943776-307EBD95-8E0B-461C-A170-450F98BB935F

Q34943776-3B527B73-AA38-436A-B893-C063A911B7FE

Q34943776-45A58561-EBAC-4E6F-8311-37E283289234

Q34943776-4DDA77A0-65CE-4745-8838-8E24E0EA0A56

Q34943776-5C78FE70-5EFC-4A6B-9885-CE12E2E9AA41

Q34943776-5EE69CB7-C9DA-400B-9463-E6F36D2DA8B3

Q34943776-69BA06A7-01F7-4B34-86E8-1FD23E48EDB3

P304

Q34943776-7A69AB6E-5B9A-4412-B26D-C389E3692CE5

P31

Q34943776-7ACD5213-F34C-4675-B156-C817E3E62263

P356

Q34943776-E1571878-0B3B-46CD-9C8B-F77421CEAF1C

P433

Q34943776-62E89AD1-2526-4032-8D4B-3664D6086BE2

P478

Q34943776-84B61BD2-2F97-4474-B81A-17A8B81A23B8

P50

Q34943776-865B11AF-7C66-421E-8301-03BB010D9C9A

Q34943776-8B1AF0CD-5886-4B6A-84E2-F1F5D5ECB01F

Q34943776-9E864FA1-04C2-47B1-A200-BE0828F49E59

P577

Q34943776-BCE90DE9-4A22-4552-BD97-05206CF5A969

P698

Q34943776-29A091BB-617A-4140-94A4-38A3C86FD727

P921

Q34943776-CCB8FBE1-0F1A-4C0C-A144-39DE2EB5058A

P932

Q34943776-1C2FAD6E-2FFA-4071-9AF3-9BA0FAE41B6E

P356

2159-8290.CD-14-0863

P1433

Cancer Discovery

P1476

The vigorous immune microenvir ...... ounter-inhibitory checkpoints.

@en

P2093

Ada Tam

http://www.w3.org/2001/XMLSchema#string

Brandon S Luber

http://www.w3.org/2001/XMLSchema#string

Cynthia L Sears

http://www.w3.org/2001/XMLSchema#string

Drew M Pardoll

http://www.w3.org/2001/XMLSchema#string

Elizabeth C Wicks

http://www.w3.org/2001/XMLSchema#string

Elizabeth M Hechenbleikner

http://www.w3.org/2001/XMLSchema#string

Franck Housseau

http://www.w3.org/2001/XMLSchema#string

Hao Wang

http://www.w3.org/2001/XMLSchema#string

Hongni Fan

http://www.w3.org/2001/XMLSchema#string

Janis M Taube

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

Microsatellite instability in colorectal cancer

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

The blockade of immune checkpoints in cancer immunotherapy

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

P304

43-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2159-8290.CD-14-0863

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth W Kinzler

Bert Vogelstein

P577

2014-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25358689

http://www.w3.org/2001/XMLSchema#string

P921

P932

4293246

http://www.w3.org/2001/XMLSchema#string